Results 281 to 290 of about 9,385,080 (408)
Sexual Health, Pleasure, Justice, and Well-Being in People With Rheumatic and Musculoskeletal Diseases: A Scoping Review Protocol. [PDF]
Giardulli B+9 more
europepmc +1 more source
Objective: To examine the relation of sleep problems to pain outcomes in people with hand osteoarthritis, and the extent to which central sensitization mediates these relationships.
Daniel H. Bordvik+6 more
doaj
Objectives Chondrocyte metabolic dysfunction plays an important role in osteoarthritis (OA) development during aging and obesity. Protein post‐translational modifications (PTMs) have recently emerged as an important regulator of cellular metabolism. We aim to study one type of PTM, lysine malonylation (MaK) and its regulator Sirt5 in OA development ...
Huanhuan Liu+11 more
wiley +1 more source
A bibliometric and visualized analysis of extracellular vesicles in degenerative musculoskeletal diseases (from 2006 to 2024). [PDF]
Yang JJ+6 more
europepmc +1 more source
Rééducation Posturale Globale in musculoskeletal diseases: scientific evidence and clinical practice
Carla Vanti+5 more
openalex +2 more sources
A Case of Musculoskeletal Tuberculosis Mimicking Adult-Onset Still's Disease [PDF]
Jin Kyeong Cho+6 more
openalex +1 more source
Objective To assess the incidence of major adverse cardiovascular events (MACE) in RA patients treated with JAKi, TNF‐inhibitors (TNFi) or biologic Disease‐Modifying Anti‐Rheumatic Drugs with other modes of action (bDMARD‐OMA) in a multi‐country, real‐world population.
Romain Aymon+28 more
wiley +1 more source
Screening and diagnosis of sarcopenia in rheumatic and musculoskeletal diseases: findings from a cross-sectional study. [PDF]
Pardali EC+16 more
europepmc +1 more source
Global burden of osteoarthritis and musculoskeletal diseases [PDF]
Anthony D. Woolf
openalex +1 more source
Paradoxical Activation of Entheseal Myeloid Cells by JAK1 and TYK2 Inhibitors via IL10 Antagonism
Background JAK inhibition (JAKi) is effective in seronegative spondyloarthropathy (SpA) spectrum disorders, but TYK2 inhibition failed in SpA spectrum ulcerative colitis, and tofacitinib showed minimal benefit in Crohn's Disease, which highlights the complex role for JAK‐STAT signaling in different inflammatory processes. In this study, we investigated
Sami Giryes+14 more
wiley +1 more source